Skip to content

CelltaGen

셀타젠 Genetic Genotyping

Menu
  • Home
  • RNA
  • Assay
  • DNA
  • Plant
  • Guinea
  • Distributors
Menu

VSIG4 Rabbit Polyclonal Antibody

VSIG4 Rabbit Polyclonal Antibody

Polyclonal VSIG4 Antibody (C-term)

APR04368G Leading Biology 0.1ml 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human VSIG4 (C-term). This antibody is tested and proven to work in the following applications:

VSIG4 Antibody (HRP)

20-abx316697 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

VSIG4 Antibody (FITC)

20-abx316698 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

VSIG4 Antibody (Biotin)

20-abx316699 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Anti-VSIG4 antibody

STJ192339 St John's Laboratory 200 µl 236.4 EUR
Description: Unconjugated Rabbit polyclonal to VSIG4

VSIG4 siRNA

20-abx939568 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

VSIG4 Antibody, HRP conjugated

1-CSB-PA896869LB01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against VSIG4. Recognizes VSIG4 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

VSIG4 Antibody, FITC conjugated

1-CSB-PA896869LC01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against VSIG4. Recognizes VSIG4 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

VSIG4 Antibody, Biotin conjugated

1-CSB-PA896869LD01HU Cusabio
  • 380.40 EUR
  • 402.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against VSIG4. Recognizes VSIG4 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

VSIG4 cloning plasmid

CSB-CL896869HU-10ug Cusabio 10ug 279.6 EUR
Description: A cloning plasmid for the VSIG4 gene.

VSIG4 Recombinant Protein

91-499 ProSci 0.05 mg 537.9 EUR
Description: V-Set and Immunoglobulin Domain-Containing Protein 4 (VSIG4) is a 45-50 kDa macrophage-specific transmembrane glycoprotein that belongs to the B7 family-related protein and an Ig superfamily member. In contrast to the B7 family members which contain two IgG domains, VSIG4 contains one complete V-type Ig domain and a truncated C-type I g domain. VSIG4 is abundantly expressed in several fetal tissues. In adult tissues, the highest expression of VSIG4 is in lung and placenta. It is also expressed in resting macrophages. No VSIG4 expression appears to be present in T and B cells. The specific expression of VSIG4 on resting macrophages in tissue suggests that this inhibitory ligand may be important for the maintenance of T cell unresponsiveness in healthy tissues. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. VSIG4 is a phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. It is a potent inhibitor of the alternative complement pathway convertases. Human VSIG4 is 399 amino acids (aa) in length. It is a type I transmembrane (TM) glycoprotein that contains a 264 aa extracellular domain (ECD) (aa 20 - 283) and a 95 aa cytoplasmic region.

VSIG4 Recombinant Protein

91-940 ProSci 0.05 mg 537.9 EUR
Description: V-set and immunoglobulin domain-containing protein 4(VSIG4) is a transmembrane protein contains a signal peptide, a V-type Ig-like domain, a C2-type Ig-like domain, several potential O-glycosylation sites, and an intracellular domain with 2 potential phosphorylation sites and is structurally related to the B7 family of immune regulatory proteins. This protein is also a receptor for the complement component 3 fragments C3b and iC3b.The main function is strong negative regulator of T-cell proliferation and IL2 production and it is also potent inhibitor of the alternative complement pathway convertases. It abundantly expressed in several fetal tissues such as adult tissues, highest expression in lung and placenta and it also expressed in resting macrophages.

VSIG4 Blocking Peptide

33R-9726 Fitzgerald 100 ug 216 EUR
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of VSIG4 antibody, catalog no. 70R-1905

VSIG4 Recombinant Protein

96-780 ProSci 0.1 mg 588.3 EUR
Description: V-set and immunoglobulin domain-containing protein 4 (VSIG4) is also known as Protein Z39Ig, is a type I transmembrane glycoprotein. VSIG4 is a B7 family-related protein and an Ig superfamily member. VSIG4 contains two Ig-like (immunoglobulin-like) domains. VSIG4 is abundantly expressed in several fetal tissues. In adult tissues, the highest expression of VSIG4 is in lung and placenta. VSIG4 functions as a negative regulator of T cell activation, and may be involved in the maintenance of peripheral T cell tolerance, and is also identified as a potent suppressor of established inflammation. VSIG4 is a phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production.

Human VSIG4 shRNA Plasmid

20-abx957754 Abbexa
  • 961.20 EUR
  • 1345.20 EUR
  • 150 µg
  • 300 µg

Human VSIG4 ELISA KIT

ELI-15017h Lifescience Market 96 Tests 988.8 EUR

Recombinant Human VSIG4 Protein

RP00286 Abclonal 20 μg 242.4 EUR

VSIG4 Recombinant Protein (Mouse)

RP185009 ABM 100 ug Ask for price

VSIG4 Recombinant Protein (Rat)

RP237083 ABM 100 ug Ask for price

Recombinant Mouse VSIG4 (C-6His)

CP83-10ug Novoprotein 10ug 169.2 EUR
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Mouse VSIG4 (C-6His)

CP83-1mg Novoprotein 1mg 2008.8 EUR
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Mouse VSIG4 (C-6His)

CP83-500ug Novoprotein 500ug 1423.2 EUR
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Mouse VSIG4 (C-6His)

CP83-50ug Novoprotein 50ug 363.6 EUR
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

VSIG4 ELISA Kit (Human) (OKCA00860)

OKCA00860 Aviva Systems Biology 96 Wells 999.6 EUR
Description: Description of target: Phagocytic receptor, strong negative regulator of T-cell proliferation and IL2 production. Potent inhibitor of the alternative complement pathway convertases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 7.81 pg/mL

Vsig4 ORF Vector (Rat) (pORF)

ORF079029 ABM 1.0 ug DNA 607.2 EUR

Vsig4 ORF Vector (Mouse) (pORF)

ORF061671 ABM 1.0 ug DNA 607.2 EUR

VSIG4 ELISA Kit (Human) (OKEH08599)

OKEH08599 Aviva Systems Biology 96 Wells 1075.2 EUR
Description: Description of target: This gene encodes a v-set and immunoglobulin-domain containing protein that is structurally related to the B7 family of immune regulatory proteins. The encoded protein may be a negative regulator of T-cell responses. This protein is also a receptor for the complement component 3 fragments C3b and iC3b. Alternate splicing results in multiple transcript variants.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.22ng/ml

VSIG4 ORF Vector (Human) (pORF)

ORF011484 ABM 1.0 ug DNA 114 EUR

Human CellExp? VSIG4, human recombinant

P1018-10 Biovision each 248.4 EUR

Human CellExp? VSIG4, human recombinant

P1018-50 Biovision each 574.8 EUR

VSIG4 sgRNA CRISPR Lentivector set (Human)

K2620901 ABM 3 x 1.0 ug 406.8 EUR

Vsig4 sgRNA CRISPR Lentivector set (Mouse)

K4242501 ABM 3 x 1.0 ug 406.8 EUR

Vsig4 sgRNA CRISPR Lentivector set (Rat)

K7367501 ABM 3 x 1.0 ug 406.8 EUR

VSIG4 sgRNA CRISPR Lentivector (Human) (Target 1)

K2620902 ABM 1.0 ug DNA 184.8 EUR

VSIG4 sgRNA CRISPR Lentivector (Human) (Target 2)

K2620903 ABM 1.0 ug DNA 184.8 EUR

VSIG4 sgRNA CRISPR Lentivector (Human) (Target 3)

K2620904 ABM 1.0 ug DNA 184.8 EUR

Vsig4 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K4242502 ABM 1.0 ug DNA 184.8 EUR

Vsig4 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K4242503 ABM 1.0 ug DNA 184.8 EUR

Vsig4 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K4242504 ABM 1.0 ug DNA 184.8 EUR

Vsig4 sgRNA CRISPR Lentivector (Rat) (Target 1)

K7367502 ABM 1.0 ug DNA 184.8 EUR

Vsig4 sgRNA CRISPR Lentivector (Rat) (Target 2)

K7367503 ABM 1.0 ug DNA 184.8 EUR

Vsig4 sgRNA CRISPR Lentivector (Rat) (Target 3)

K7367504 ABM 1.0 ug DNA 184.8 EUR

VSIG4 Protein Vector (Human) (pPB-C-His)

PV045933 ABM 500 ng 394.8 EUR

VSIG4 Protein Vector (Human) (pPB-N-His)

PV045934 ABM 500 ng 394.8 EUR

VSIG4 Protein Vector (Human) (pPM-C-HA)

PV045935 ABM 500 ng 394.8 EUR

VSIG4 Protein Vector (Human) (pPM-C-His)

PV045936 ABM 500 ng 394.8 EUR

VSIG4 Protein Vector (Rat) (pPB-C-His)

PV316114 ABM 500 ng 723.6 EUR
×

VSIG4 Rabbit Polyclonal Antibody

Recent Posts

  • Compare antibodies lab reagents for research
  • Compare polyclonal lab reagents for research
  • Assay Lab Reagents for Research
  • TEST Lab Reagents for Research
  • Advances on human amniotic epithelial cells and its clinical application potential

RSS Trends in Genetics

  • People with disability and privacy in precision medicine research: what’s at stake?
  • Complexities of mammalian transcriptome revealed by targeted RNA enrichment techniques
  • Clinical progress in genome-editing technology and in vivo delivery techniques
  • Polygenic sex determination in vertebrates – is there any such thing?
  • Emerging regulatory mechanisms of noncoding RNAs in topologically associating domains
  • RNA out of the mist
  • Consequences of trisomy syndromes – 21 and beyond
  • A proposed metric set for evaluation of genome assembly quality
  • Host genetic variability and determinants of severe COVID-19

Categories

  • 4 Host
  • 96T
  • apoptosis
  • array
  • Assay
  • Bacteria
  • DNA
  • Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential.
  • GMO
  • Goat
  • Green
  • Guinea
  • Malignant transformation in a Breast Adenomyoepithelioma Caused by Amplification of c-MYC: A Common pathway to Cancer in a Rare Entity.
  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
  • Pig
  • Pigeon
  • PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription.
  • Plant
  • plasmid
  • Plate
  • PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
  • RNA
  • SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.

Recent Posts

  • Compare antibodies lab reagents for research
  • Compare polyclonal lab reagents for research
  • Assay Lab Reagents for Research
  • TEST Lab Reagents for Research
  • Advances on human amniotic epithelial cells and its clinical application potential

RSS Trends in Genetics

  • People with disability and privacy in precision medicine research: what’s at stake?
  • Complexities of mammalian transcriptome revealed by targeted RNA enrichment techniques
  • Clinical progress in genome-editing technology and in vivo delivery techniques
  • Polygenic sex determination in vertebrates – is there any such thing?
  • Emerging regulatory mechanisms of noncoding RNAs in topologically associating domains
  • RNA out of the mist
  • Consequences of trisomy syndromes – 21 and beyond
  • A proposed metric set for evaluation of genome assembly quality
  • Host genetic variability and determinants of severe COVID-19

Categories

  • 4 Host
  • 96T
  • apoptosis
  • array
  • Assay
  • Bacteria
  • DNA
  • Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential.
  • GMO
  • Goat
  • Green
  • Guinea
  • Malignant transformation in a Breast Adenomyoepithelioma Caused by Amplification of c-MYC: A Common pathway to Cancer in a Rare Entity.
  • Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
  • Pig
  • Pigeon
  • PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription.
  • Plant
  • plasmid
  • Plate
  • PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
  • RNA
  • SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.

Recent Posts

  • Compare antibodies lab reagents for research
  • Compare polyclonal lab reagents for research
  • Assay Lab Reagents for Research
  • TEST Lab Reagents for Research
  • Advances on human amniotic epithelial cells and its clinical application potential
© 2023 CelltaGen | Powered by Superbs Personal Blog theme